TargetRx CEO Wins Philadelphia Business Journal's 40 Under 40 Award

Mike Luby Honored for Outstanding Contributions to Pharmaceutical    Industry and Commitment to Greater Philadelphia Business Community 

Horsham, PA - April 10, 2006 - TargetRx, a pharmaceutical sales and marketing effectiveness company, today announced that the Philadelphia Business Journal has selected CEO, President and Co-founder Mike Luby as a 40 Under 40 Award winner. Luby was honored for his role in the development and leadership of TargetRx and for his commitment to the greater Philadelphia business community.

Each year, the Philadelphia Business Journal recognizes 40 individuals under the age of 40 who are proven performers in their respective industries and communities. These dynamic up and comers help shape the community in ways that make greater Philadelphia a better place to work and live.

"Mike Luby has established the vision for TargetRx and has charted the course for the Company's success," said Richard Kollender, a partner at Quaker BioVentures and a board member of TargetRx. "This is great recognition for Mike and for all of TargetRx."

"I am honored to receive this recognition as a leader in the Philadelphia region," said Luby.

Under Luby's leadership since inception in 1999, TargetRx has succeeded in raising more than $50 million in capital, creating more than 100 jobs in the region, and securing clients in the majority of the top 30 pharmaceutical companies worldwide. The Company offers a new approach to improving the sales and marketing effectiveness of pharmaceutical companies by providing clients with unique insights that enable greater effectiveness and efficiency in their sales and marketing execution. TargetRx recently received notice of allowance from the U.S. Patent and Trademark Office for the Company's lead patent, A Method and System for Evaluating the Effectiveness of Marketing Strategies, relating to the Company's unique approach to collecting and analyzing data for its core product offerings.

A former sales and marketing executive at Merck and a graduate of the Wharton School of Business, Luby is an active member of the Philadelphia community. He has spearheaded the Company's recruiting efforts at the University of Pennsylvania, Princeton University and Saint Joseph's University. He has participated in the Entrepreneur-in-Residence program at Wharton and has also served as a guest lecturer at the Saint Joseph's University Pharmaceutical Marketing Program. In addition, Luby is an active parishioner at St. Thomas of Villanova Catholic Church, where he serves as the secretary of the Parish Pastoral Council.

Luby will be honored at an awards banquet to be held on Tuesday, May 2, 2006 at the Sheraton Society Hill hotel in Philadelphia.

About TargetRx

TargetRx provides pharmaceutical and biotech companies with unique insight into the true drivers of product choice and adoption for their brands, helping clients to confidently take the actions that will grow their businesses and help patients. Serving the majority of the top 30 pharmaceutical and biotech companies, TargetRx enables clients to significantly improve the launch of new products and indications, physician segmentation and targeting, creation of professional messaging and materials, and sales and marketing execution and effectiveness. All TargetRx solutions are powered by our AdvantageBuilderSM normative database and validated predictive models, created from capturing in-depth physician attitudes on the "four forces" of prescribing - product, payor, promotion and patient - on new launches, marketing campaigns and physician-rep interactions on over 500 pipeline and inline brands and modeling these attitudes against actual prescribing behavior. For more information, visit www.targetrx.com.

Media Contact:

Joe Ford
Phone: 215-444-8722
jford@targetrx.com